References
- Chow, S. C. 2013. Biosimilars, design and analysis of follow-on biologics. New York: Chapman & Hall/CRC Press.
- Chow, S. C. 2018. Analytical similarity assessment in biosimilar product development. New York: Chapman & Hall/CRC Press.
- US Food and Drug Administration. 2017. Statistical approaches to evaluate analytical similarity: guidance for industry. Silver Springs, MD: US Department of Health and Human Services.
- Fisher, R. A. 1930. Inverse probability. Proceedings of the Cambridge Philosophical Society 26:528–535. (Collected Papers 84.). doi:10.1017/S0305004100016297.
- Fisher, R. A. 1935. The fiducial argument in statistical inference. Annals of Human Genetics 6 (4):391–398.
- Kang, S. H., and S. C. Chow. 2017. Statistical assessment of biosimilarity based on relative distance between follow-on biologics. Statistics in Medicine 32 (3):382–392. doi:10.1002/sim.5582.
- Seidenfeld, T. 1992. R. A. Fisher’s fiducial argument and Bayes’ Theorem. Statistical Science. 7(3):358–368. Retrieved from http://www.jstor.org/stable/2246072. doi:10.1214/ss/1177011232.
- Zheng, J., S. C. Chow, and M. Yuan. 2017. On assessing bioequivalence and interchangeability between generics based on indirect comparisons. Statistics in Medicine 36 (19):2978–2993. doi:10.1002/sim.7326.